Ezetimibe/Atorvastatin Calcium Hydrate

依折麦布/阿托伐他汀钙

Report date: 2026/04/03 20:03:44

Base Information

Drug NameEzetimibe/Atorvastatin Calcium Hydrate
Drug Alias NameAtorvastatin Calcium Hydrate and Ezetimibe依折麦布和阿托伐他汀钙Ezetimibe and Atorvastatin Calcium Hydrate依折麦布•阿托伐他汀钙Ezetimibe• Atorvastatin Calcium Hydrate +[25] 
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionHMG-CoA reductase inhibitorsCholesterol absorption inhibitorsNiemann-Pick C1-like protein 1 inhibitors
TargetsHMG-CoA reductaseNiemann-Pick C1-like protein 1
Therapy Area/IndicationsHeterozygous familial hypercholesterolemiaHomozygous familial hypercholesterolemiaHypercholesterolemia +[6] 
Global Approved IndicationsHomozygous familial hypercholesterolemiaHypercholesterolemiaHyperlipidemias +[4] 
Approved Indications in ChinaHomozygous familial hypercholesterolemiaHypercholesterolemia
Original Approved Country/TerritoryUnited States
Original Approved Date2013/05/03
Country/TerritoryUnited StatesSouth KoreaMainland China +[4] 
CombinationsYes EzetimibeAtorvastatin Calcium Hydrate
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesMerck Sharp & Dohme Corp
China Registration ClassN/A

Develop Information

Active CompaniesOrganon China BvMerck Sharp & Dohme CorpDaewon Pharmaceutical Co Ltd +[4] 
Inactive CompaniesOrganonMerck Sharp & Dohme BvMerck Sharp & Dohme Ltd +[6] 
Active IndicationsHomozygous familial hypercholesterolemiaHypercholesterolemiaDyslipidemias +[4] 
Inactive IndicationsHeterozygous familial hypercholesterolemiaHyperlipidemias

Other Information

ATC CodeC10BA05
Related LinksWikipediaKEGG